MyAverix Finance
US · Healthcare
Aardvark Therapeutics, Inc. Common Stock (AARD)
Biotechnology
Aardvark Therapeutics, Inc. Common Stock (AARD) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for AARD
Aardvark Therapeutics, Inc. Common Stock (AARD) — FAQ
What is AARD's P/E ratio?
The price-to-earnings (P/E) ratio for Aardvark Therapeutics, Inc. Common Stock (AARD) is 25.00 (data as of 2026-05-23).
Does Aardvark Therapeutics, Inc. Common Stock pay a dividend?
Dividend yield is not available in the current snapshot for Aardvark Therapeutics, Inc. Common Stock (AARD). Check the MyAverix Finance app for the latest dividend data.
What sector is Aardvark Therapeutics, Inc. Common Stock in?
Aardvark Therapeutics, Inc. Common Stock (AARD) is classified in the Healthcare sector (Biotechnology industry).
What exchange is AARD listed on?
AARD is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.